Article Information
History
- March 16, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rebecca Webster1,
- Hayley Mitchell1,
- Jenny M. Peters1,
- Juanita Heunis1,
- Brighid O’Neill1,
- Jeremy Gower1,
- Sean Lynch1,
- Helen Jennings1,
- Fiona H. Amante1,
- Stacey Llewellyn1,
- Louise Marquart1,
- Adam J. Potter1,
- Geoffrey W. Birrell3,
- Michael D. Edstein3,
- G. Dennis Shanks3,
- James S. McCarthy1,2 and
- Bridget E. Barber1,*
- 1QIMR Berghofer Medical Research Institute, Brisbane, Australia
- 2The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
- 3Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
- ↵*Corresponding author:
Dr. Bridget E. Barber. QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston 4006, Australia. Email: bridget.barber{at}qimrberghofer.edu.au. Telephone: +61 7 3362 0498.
Posted March 16, 2022.
Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum
